<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Propranolol; Propranolol: cardiovascular; Propranolol: see also Beta-adrenoceptor blocking drugs; Portal hypertension; Propranolol; Angilol (propranolol); Syprol (propranolol); Half-Inderal LA; Propranolol; Bedranol SR (propranolol); Half-Beta-Prograne (propranolol); Inderal-LA; Propranolol; Bedranol SR (propranolol); Beta-Prograne; Slo-Pro (propranolol)" /><meta name="IX" content="Propranolol: cardiovascular; Portal hypertension; Propranolol; Angilol (propranolol); Syprol (propranolol); Half-Inderal LA; Propranolol; Bedranol SR (propranolol); Half-Beta-Prograne (propranolol); Inderal-LA; Propranolol; Bedranol SR (propranolol); Beta-Prograne; Slo-Pro (propranolol)" /><meta name="IXN" content="Propranolol: see also Beta-adrenoceptor blocking drugs" /><meta name="IXM" content="Propranolol" /><title>PROPRANOLOL HYDROCHLORIDE: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="2456.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="2456.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=2456.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="2455.htm">2.4 Beta-adrenoceptor blocking drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2455.htm" title="Previous: 2.4 Beta-adrenoceptor blocking drugs">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="2457.htm#_2457" title="Next: Propranolol">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382607.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Cardiovascular Drugs 24:00 &gt; β-Adrenergic Blocking Agents 24:24</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/12152-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Propranolol</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: P &gt; Interactions of Propranolol</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="2457.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.4 Beta-adrenoceptor blocking drugs &gt; PROPRANOLOL HYDROCHLORIDE</p></div></li><li><a href="2460.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Half-Inderal LA®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.4 Beta-adrenoceptor blocking drugs &gt; PROPRANOLOL HYDROCHLORIDE &gt; Modified release</p></div></li><li><a href="2461.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inderal-LA®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.4 Beta-adrenoceptor blocking drugs &gt; PROPRANOLOL HYDROCHLORIDE &gt; Modified release</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22propranolol+hydrochloride%22%22propranolol%22%22propranolol%22%22propranolol%22%22portal+hypertension%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>BNF for Children (10)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2455.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.4 Beta-adrenoceptor blocking drugs</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2456.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">PROPRANOLOL HYDROCHLORIDE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.4 Beta-adrenoceptor blocking drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2457.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.4 Beta-adrenoceptor blocking drugs &gt; PROPRANOLOL HYDROCHLORIDE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22propranolol+hydrochloride%22%22propranolol%22%22propranolol%22%22propranolol%22%22portal+hypertension%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (10)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e978353.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; P</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a582176.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol Hydrochloride</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0015s0475.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/p35-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol hydrochloride</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/6301-g.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/07840.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; P &gt; PR</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E8E3E0R0D69.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Propranolol</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; P</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c317.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Propranolol hydrochloride</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; P</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_2456">PROPRANOLOL HYDROCHLORIDE</h1><?highlighter on?><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i793.htm" title="Go to appendix 1">Propranolol</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see under Dose</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF"><span id="_2456.1">see <a title="target-block: Beta blocker cautions" href="2455.htm#_2455.1">notes above</a>; also avoid abrupt
withdrawal especially in ischaemic heart disease; first-degree AV block; portal hypertension
(risk of deterioration in liver function); diabetes; history of
obstructive airways disease (introduce cautiously and monitor lung
function—see <a title="BNF:target-block: Beta blocker cautions" href="2455.htm#_2455.1">notes above</a>); myasthenia gravis; symptoms of hypoglycaemia and thyrotoxicosis may be masked (also see notes above); psoriasis; history of hypersensitivity—may increase sensitivity
to allergens and result in more serious hypersensitivity response, also may reduce response to adrenaline (epinephrine) (see also <a title=" Allergic emergencies" href="3121.htm#_3121">section 3.4.3</a>); <b>interactions: </b>Appendix 1
(beta-blockers), </span><b>important: </b>verapamil
interaction, see also  VERAPAMIL <a title=" Calcium-channel blockers" href="2616.htm#_2616">section 2.6.2</a> </p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF"><span id="_2456.2">asthma (but see <a title="BNF:target-block: Beta blocker cautions" href="2455.htm#_2455.1">notes above</a>), uncontrolled heart failure, Prinzmetal’s angina, marked bradycardia, hypotension, sick sinus syndrome, second- or third- degree AV block, cardiogenic shock, metabolic acidosis, severe peripheral
arterial disease; phaeochromocytoma (apart from specific
use with alpha-blockers, see also <a title="target-block: Beta blockers and phaeochromocytoma" href="2455.htm#_2455.2">notes above</a>)</span></p><div class="cAV"><h3>Bronchospasm</h3> <p class="cAX">Beta-blockers, including those considered
to be cardioselective, should usually be avoided in patients with
a history of asthma or bronchospasm. However, when there is no alternative,
a cardioselective beta-blocker can be given to these patients with
caution and under specialist supervision.</p></div></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">reduce oral dose</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">manufacturer advises caution—dose reduction may be required</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">see <a title="BNF:target-block: Beta-blockers and pregnancy" href="2455.htm#_203966">notes above</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">see <a title="BNF:target-block: Beta-blockers and breast-feeding" href="2455.htm#_203967">notes above</a></p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see notes above; also gastro-intestinal disturbances;
bradycardia, heart failure, hypotension, conduction disorders, peripheral
vasoconstriction (including exacerbation of intermittent claudication
and Raynaud’s phenomenon); bronchospasm (see above), dyspnoea; headache,
fatigue, sleep disturbances, paraesthesia, dizziness, vertigo, psychoses;
sexual dysfunction; purpura, thrombocytopenia; visual disturbances;
exacerbation of psoriasis, alopecia; <i>rarely</i> rashes
and dry eyes (reversible on withdrawal); <b>overdosage:</b> see <a title="monograph-family: Beta-blockers" href="29541.htm#_29541">Emergency Treatment of Poisoning</a></p></div><div class="cAF"><h2>Dose</h2> <p class="cR"><span class="cU">By mouth</span>, hypertension, initially
80 mg twice daily, increased at weekly intervals as required; maintenance
160–320 mg daily</p><p class="cS">Prophylaxis of variceal bleeding in portal hypertension, initially
40 mg twice daily, increased to 80 mg twice daily according to heart
rate; max. 160 mg twice daily</p><p class="cS">Phaeochromocytoma (only with an alpha-blocker), 60 mg daily
for 3 days before surgery <i>or</i> 30 mg daily in patients
unsuitable for surgery</p><p class="cS">Angina, initially 40 mg 2–3 times daily; maintenance 120–240 mg
daily</p><p class="cS">Arrhythmias, hypertrophic cardiomyopathy, anxiety tachycardia,
and thyrotoxicosis (adjunct), 10–40 mg 3–4 times daily</p><p class="cS">Anxiety with symptoms such as palpitation, sweating, tremor,
40 mg once daily, increased to 40 mg 3 times daily if necessary</p><p class="cS">Prophylaxis after myocardial infarction, 40 mg 4 times daily
for 2–3 days, then 80 mg twice daily, beginning 5 to 21 days after
infarction</p><p class="cS">Essential tremor, initially 40 mg 2–3 times daily; maintenance
80–160 mg daily</p><p class="cS">Migraine prophylaxis, 80–240 mg daily in divided doses</p><p class="cR"><span class="cU">By intravenous injection</span>, arrhythmias
and thyrotoxic crisis, 1 mg over 1 minute; if necessary repeat at
2-minute intervals; max. total dose 10 mg (5 mg in anaesthesia)</p><div class="cAT"><h3>Note</h3> <p class="cAX">Excessive bradycardia can be countered with <span class="cU">intravenous injection</span> of <span>atropine sulphate</span> 0.6–2.4 mg in divided doses of 600 micrograms; for <b>overdosage</b> see <a title="monograph-family: Beta-blockers" href="29541.htm#_29541">Emergency Treatment of Poisoning</a> </p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="2457.htm#_2457" title="Propranolol">Propranolol</a></li><li id="_2459__2459"><a href="2459.htm#_2459" title="Modified release">Modified release</a><ul style="display: none"><li><a href="2460.htm#_2460" title="Half-Inderal LA®">Half-Inderal LA®</a></li><li><a href="2461.htm#_2461" title="Inderal-LA®">Inderal-LA®</a></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2455.htm">Previous: 2.4 Beta-adrenoceptor blocking drugs</a> | <a class="top" href="2456.htm#">Top</a> | <a accesskey="]" href="2457.htm#_2457" title="Propranolol">Next: Propranolol</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>